Cargando…

The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study

BACKGROUND: Obesity is a growing problem worldwide, especially in countries with improved socioeconomic circumstances. Also, in the Netherlands the incidence of overweight and obesity is rising. There is increasing evidence on the association between obesity and tumorigenesis. Of all cancer types, e...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Bosch, A. A. S., Pijnenborg, J. M. A., Romano, A., Haldorsen, I. S., Werner, H. M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612461/
https://www.ncbi.nlm.nih.gov/pubmed/36301824
http://dx.doi.org/10.1371/journal.pone.0276516
_version_ 1784819774926094336
author van den Bosch, A. A. S.
Pijnenborg, J. M. A.
Romano, A.
Haldorsen, I. S.
Werner, H. M. J.
author_facet van den Bosch, A. A. S.
Pijnenborg, J. M. A.
Romano, A.
Haldorsen, I. S.
Werner, H. M. J.
author_sort van den Bosch, A. A. S.
collection PubMed
description BACKGROUND: Obesity is a growing problem worldwide, especially in countries with improved socioeconomic circumstances. Also, in the Netherlands the incidence of overweight and obesity is rising. There is increasing evidence on the association between obesity and tumorigenesis. Of all cancer types, endometrial cancer (EC) has the strongest positive correlation with obesity. Obesity is generally defined as a body mass index (BMI) >30, yet does not cover the differences in fat distribution in visceral and subcutaneous compartments. Visceral fat is assumed to be relatively more metabolically active and likely negative prognostic biomarker in non-endometrioid EC. Whereas subcutaneous fat is mainly responsible for oestrogen production through increased aromatase activity. OBJECTIVE: The aim of this study is to compare hormone levels and inflammatory markers after bilateral salpingo-oophorectomy (BSO) in obese and non-obese patients. Secondary objectives are to compare the effect of fat distribution and diagnosis (benign vs. EC) on the observed changes in hormone levels and inflammatory markers, and to compare the effect of BSO on menopausal complaints. METHODS: Prospective multicentre observational cohort study. A total of 160 patients will be included, of which 80 patients with a normal BMI (18–25 kg/m2) and 80 patients with an obese BMI >32–35 kg/m2. Preoperative abdominal CT will be performed and fasting venous blood samples are obtained for hormone levels and inflammation markers analysis. During surgery, adipose tissue biopsies of subcutaneous and visceral (omental and intestinal epiploic fat) compartments will be collected and stored fresh frozen. In addition a fasting blood draw six weeks after surgery will be obtained. All subjects will fill in two questionnaires before surgery and one after surgery. DISCUSSION: We hypothesize that BMI, the type of fat distribution, and possibly the underlying pathology significantly influence in hormone levels, and systemic inflammation changes after BSO. Previous studies have found several clues for a relationship between obesity and endometrial cancer. We expect that our study will contribute to pinpoint the exact differences between ‘healthy obesity’ and ‘unhealthy obesity’ and will help to identify patients that are more at risk of developing cancer (or possibly suffer from other related problems such as cardiovascular problems e.g.).
format Online
Article
Text
id pubmed-9612461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-96124612022-10-28 The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study van den Bosch, A. A. S. Pijnenborg, J. M. A. Romano, A. Haldorsen, I. S. Werner, H. M. J. PLoS One Study Protocol BACKGROUND: Obesity is a growing problem worldwide, especially in countries with improved socioeconomic circumstances. Also, in the Netherlands the incidence of overweight and obesity is rising. There is increasing evidence on the association between obesity and tumorigenesis. Of all cancer types, endometrial cancer (EC) has the strongest positive correlation with obesity. Obesity is generally defined as a body mass index (BMI) >30, yet does not cover the differences in fat distribution in visceral and subcutaneous compartments. Visceral fat is assumed to be relatively more metabolically active and likely negative prognostic biomarker in non-endometrioid EC. Whereas subcutaneous fat is mainly responsible for oestrogen production through increased aromatase activity. OBJECTIVE: The aim of this study is to compare hormone levels and inflammatory markers after bilateral salpingo-oophorectomy (BSO) in obese and non-obese patients. Secondary objectives are to compare the effect of fat distribution and diagnosis (benign vs. EC) on the observed changes in hormone levels and inflammatory markers, and to compare the effect of BSO on menopausal complaints. METHODS: Prospective multicentre observational cohort study. A total of 160 patients will be included, of which 80 patients with a normal BMI (18–25 kg/m2) and 80 patients with an obese BMI >32–35 kg/m2. Preoperative abdominal CT will be performed and fasting venous blood samples are obtained for hormone levels and inflammation markers analysis. During surgery, adipose tissue biopsies of subcutaneous and visceral (omental and intestinal epiploic fat) compartments will be collected and stored fresh frozen. In addition a fasting blood draw six weeks after surgery will be obtained. All subjects will fill in two questionnaires before surgery and one after surgery. DISCUSSION: We hypothesize that BMI, the type of fat distribution, and possibly the underlying pathology significantly influence in hormone levels, and systemic inflammation changes after BSO. Previous studies have found several clues for a relationship between obesity and endometrial cancer. We expect that our study will contribute to pinpoint the exact differences between ‘healthy obesity’ and ‘unhealthy obesity’ and will help to identify patients that are more at risk of developing cancer (or possibly suffer from other related problems such as cardiovascular problems e.g.). Public Library of Science 2022-10-27 /pmc/articles/PMC9612461/ /pubmed/36301824 http://dx.doi.org/10.1371/journal.pone.0276516 Text en © 2022 van den Bosch et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
van den Bosch, A. A. S.
Pijnenborg, J. M. A.
Romano, A.
Haldorsen, I. S.
Werner, H. M. J.
The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
title The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
title_full The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
title_fullStr The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
title_full_unstemmed The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
title_short The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
title_sort role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the endocrine study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612461/
https://www.ncbi.nlm.nih.gov/pubmed/36301824
http://dx.doi.org/10.1371/journal.pone.0276516
work_keys_str_mv AT vandenboschaas theroleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT pijnenborgjma theroleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT romanoa theroleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT haldorsenis theroleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT wernerhmj theroleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT vandenboschaas roleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT pijnenborgjma roleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT romanoa roleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT haldorsenis roleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy
AT wernerhmj roleoffatdistributionandinflammationintheoriginofendometrialcancerstudyprotocoloftheendocrinestudy